BioLife Solutions
BLFS
17 hedge funds and large institutions have $518K invested in BioLife Solutions in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
15% less capital invested
Capital invested by funds: $609K → $518K (-$91K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$132K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$53.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.5K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.4K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$22.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$352K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$21K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7K |
BLFS Hedge Fund Activity: Q3 2016 in Review
17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2016, worth a combined $518K — down 15% from $609K a quarter earlier.
Fund positioning in BLFS was balanced in Q3 2016: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $132K. The largest seller was Credit Suisse, exiting entirely with an estimated $352K sold.
- 17 institutional investors held BioLife Solutions (BLFS) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $518K of BioLife Solutions stock for Q3 2016, down 15% quarter-over-quarter.
- 4 funds opened new BioLife Solutions positions in Q3 2016 and 4 closed out, a net change of 0 holders.
- The largest BioLife Solutions buyer in Q3 2016 was Geode Capital Management, an estimated $132K added.
- The largest BioLife Solutions seller in Q3 2016 was Credit Suisse, an estimated $352K sold.
Based on aggregated 13F filings for Q3 2016.